S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.43 (-1.51%)
AAPL   115.08 (+0.03%)
MSFT   210.70 (-2.56%)
FB   277.33 (-2.62%)
GOOGL   1,583.80 (-3.01%)
AMZN   3,210.00 (+0.17%)
TSLA   418.50 (-0.51%)
NVDA   525.49 (-3.33%)
BABA   307.18 (-0.88%)
CGC   18.62 (-5.63%)
GE   7.37 (-3.41%)
MU   52.02 (-1.57%)
AMD   82.25 (+0.35%)
T   27.35 (-1.69%)
F   8.02 (-1.72%)
ACB   4.41 (-5.77%)
GILD   59.91 (-1.45%)
NFLX   488.84 (+0.11%)
NIO   26.01 (-4.23%)
BA   160.66 (-4.00%)
DIS   124.25 (-3.19%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.43 (-1.51%)
AAPL   115.08 (+0.03%)
MSFT   210.70 (-2.56%)
FB   277.33 (-2.62%)
GOOGL   1,583.80 (-3.01%)
AMZN   3,210.00 (+0.17%)
TSLA   418.50 (-0.51%)
NVDA   525.49 (-3.33%)
BABA   307.18 (-0.88%)
CGC   18.62 (-5.63%)
GE   7.37 (-3.41%)
MU   52.02 (-1.57%)
AMD   82.25 (+0.35%)
T   27.35 (-1.69%)
F   8.02 (-1.72%)
ACB   4.41 (-5.77%)
GILD   59.91 (-1.45%)
NFLX   488.84 (+0.11%)
NIO   26.01 (-4.23%)
BA   160.66 (-4.00%)
DIS   124.25 (-3.19%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.43 (-1.51%)
AAPL   115.08 (+0.03%)
MSFT   210.70 (-2.56%)
FB   277.33 (-2.62%)
GOOGL   1,583.80 (-3.01%)
AMZN   3,210.00 (+0.17%)
TSLA   418.50 (-0.51%)
NVDA   525.49 (-3.33%)
BABA   307.18 (-0.88%)
CGC   18.62 (-5.63%)
GE   7.37 (-3.41%)
MU   52.02 (-1.57%)
AMD   82.25 (+0.35%)
T   27.35 (-1.69%)
F   8.02 (-1.72%)
ACB   4.41 (-5.77%)
GILD   59.91 (-1.45%)
NFLX   488.84 (+0.11%)
NIO   26.01 (-4.23%)
BA   160.66 (-4.00%)
DIS   124.25 (-3.19%)
S&P 500   3,400.97 (-1.86%)
DOW   27,685.38 (-2.29%)
QQQ   280.43 (-1.51%)
AAPL   115.08 (+0.03%)
MSFT   210.70 (-2.56%)
FB   277.33 (-2.62%)
GOOGL   1,583.80 (-3.01%)
AMZN   3,210.00 (+0.17%)
TSLA   418.50 (-0.51%)
NVDA   525.49 (-3.33%)
BABA   307.18 (-0.88%)
CGC   18.62 (-5.63%)
GE   7.37 (-3.41%)
MU   52.02 (-1.57%)
AMD   82.25 (+0.35%)
T   27.35 (-1.69%)
F   8.02 (-1.72%)
ACB   4.41 (-5.77%)
GILD   59.91 (-1.45%)
NFLX   488.84 (+0.11%)
NIO   26.01 (-4.23%)
BA   160.66 (-4.00%)
DIS   124.25 (-3.19%)
Log in
NASDAQ:ENDP

Endo International Stock Forecast, Price & News

$5.55
-0.24 (-4.15 %)
(As of 10/26/2020 04:30 PM ET)
Add
Compare
Today's Range
$5.34
Now: $5.55
$5.84
50-Day Range
$2.74
MA: $3.75
$5.80
52-Week Range
$2.08
Now: $5.55
$7.10
Volume3.59 million shs
Average Volume5.79 million shs
Market Capitalization$1.28 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.32
Endo International plc manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; TESTOPEL for TRT in conditions associated with a deficiency or absence of endogenous testosterone; AVEED to treat hypogonadism; PERCOCET to treat moderate-to-moderately-severe pain; VOLTAREN gel for the relief of joint pain of osteoarthritis; LIDODERM for the relief of pain; TESTOPEL, an implantable pellet indicated for TRT in conditions; EDEX to treat erectile dysfunction; and LIDODERM a topical patch product containing lidocaine. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays; and products for the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and cardiovascular disease markets. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, and oncology. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland.
Read More
Endo International logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.1Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.95 out of 5 stars

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryPharmaceuticals
SectorMedical
Current SymbolNASDAQ:ENDP
CUSIP29264F20
Phone011-353-1268-2000
Employees3,172

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.91 billion
Cash Flow$5.14 per share
Book Value($3.82) per share

Profitability

Net Income$-422,640,000.00

Miscellaneous

Market Cap$1.28 billion
Next Earnings Date11/5/2020 (Confirmed)
OptionableOptionable
$5.55
-0.24 (-4.15 %)
(As of 10/26/2020 04:30 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ENDP News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDP and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Endo International (NASDAQ:ENDP) Frequently Asked Questions

How has Endo International's stock price been impacted by COVID-19?

Endo International's stock was trading at $3.89 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, ENDP stock has increased by 42.2% and is now trading at $5.53.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Endo International?

7 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Endo International in the last year. There are currently 2 sell ratings, 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Endo International
.

When is Endo International's next earnings date?

Endo International is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Endo International
.

How can I listen to Endo International's earnings call?

Endo International will be holding an earnings conference call on Thursday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Endo International's earnings last quarter?

Endo International plc (NASDAQ:ENDP) announced its quarterly earnings results on Wednesday, August, 5th. The company reported $0.65 earnings per share for the quarter, beating the Zacks' consensus estimate of $0.35 by $0.30. The company earned $687.59 million during the quarter, compared to analysts' expectations of $637.99 million. Endo International had a negative net margin of 5.25% and a negative return on equity of 91.41%.
View Endo International's earnings history
.

What guidance has Endo International issued on next quarter's earnings?

Endo International issued an update on its FY20 earnings guidance on Wednesday, August, 5th. The company provided earnings per share (EPS) guidance of $2.00-2.15 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.24. The company issued revenue guidance of $2.60-2.70 billion, compared to the consensus revenue estimate of $2.80 billion.

What price target have analysts set for ENDP?

7 Wall Street analysts have issued 12 month price objectives for Endo International's stock. Their forecasts range from $3.00 to $7.00. On average, they expect Endo International's stock price to reach $5.33 in the next year. This suggests that the stock has a possible downside of 3.6%.
View analysts' price targets for Endo International
.

Who are some of Endo International's key competitors?

What other stocks do shareholders of Endo International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Endo International investors own include Teva Pharmaceutical Industries (TEVA), Bausch Health Companies (BHC), Mallinckrodt (MNK), Gilead Sciences (GILD), TherapeuticsMD (TXMD), Micron Technology (MU), Cleveland-Cliffs (CLF), Pfizer (PFE), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

Who are Endo International's key executives?

Endo International's management team includes the following people:
  • Mr. Blaise Coleman, Pres, CEO & Director (Age 46, Pay $1.9M)
  • Mr. Terrance J. Coughlin, Exec. VP & COO (Age 54, Pay $1.95M)
  • Mr. Matthew Joseph Maletta, Exec. VP & Chief Legal Officer (Age 48, Pay $1.82M)
  • Mr. Patrick A. Barry, Exec. VP & Pres of Global Commercial Operations (Age 52, Pay $1.47M)
  • Mr. Mark T. Bradley, Exec. VP & CFO
  • Mr. Jack D. Boyle, Sr. VP, Controller & Chief Accounting Officer (Age 44)
  • Ms. Ruth Thorpe, Sr. VP of Information Technology & Chief Information Officer
  • Ms. Laure E. Park, Sr. VP of Investor Relations & Corp. Affairs
  • Ms. Susan Williamson, Sr. VP & Chief Compliance Officer
  • Ms. Tracy Basso, Chief HR Officer

What is Endo International's stock symbol?

Endo International trades on the NASDAQ under the ticker symbol "ENDP."

Who are Endo International's major shareholders?

Endo International's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Nisa Investment Advisors LLC (0.00%). Company insiders that own Endo International stock include Nancy J Hutson, Roger H Kimmel and William P Montague.
View institutional ownership trends for Endo International
.

Which major investors are selling Endo International stock?

ENDP stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC.
View insider buying and selling activity for Endo International
.

How do I buy shares of Endo International?

Shares of ENDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Endo International's stock price today?

One share of ENDP stock can currently be purchased for approximately $5.53.

How big of a company is Endo International?

Endo International has a market capitalization of $1.27 billion and generates $2.91 billion in revenue each year. The company earns $-422,640,000.00 in net income (profit) each year or $2.38 on an earnings per share basis. Endo International employs 3,172 workers across the globe.

What is Endo International's official website?

The official website for Endo International is www.endo.com.

How can I contact Endo International?

Endo International's mailing address is First Floor Minerva House Simmonscourt Road Ballsbridge, Dublin L2, 19355. The company can be reached via phone at 011-353-1268-2000 or via email at [email protected]

This page was last updated on 10/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.